ArticlePharmacology & therapeutics2021
Corrigendum to "MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system" [Pharmacology & Therapeutics 213 (2020) 107577].
Justus M Huelse et al.PubMed ↗Publisher ↗
No numbers read from the abstract.